Cladribine

Basic Information

Item Value
DrugBank ID DB00242
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 43

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 parameningeal embryonal rhabdomyosarcoma KG + DL
2 botryoid-type embryonal rhabdomyosarcoma of the vagina KG + DL
3 embryonal extrahepatic bile duct rhabdomyosarcoma KG + DL
4 prostate embryonal rhabdomyosarcoma KG + DL
5 extrahepatic bile duct rhabdomyosarcoma KG + DL
6 rhabdomyosarcoma (disease) KG + DL
7 liver sarcoma KG + DL
8 skeletal muscle neoplasm KG + DL
9 gestational trophoblastic neoplasm KG + DL
10 pleural adenomatoid tumor KG + DL
11 ovarian myxoid liposarcoma KG + DL
12 partial hydatidiform mole KG + DL
13 gestational uterine corpus choriocarcinoma KG + DL
14 liposarcoma KG + DL
15 pleural biphasic mesothelioma KG + DL
16 malignant peritoneal mesothelioma KG + DL
17 hydatidiform mole, recurrent KG + DL
18 fallopian tube gestational choriocarcinoma KG + DL
19 pleural epithelioid mesothelioma KG + DL
20 lymphohistiocytoid mesothelioma KG + DL
21 pleural sarcomatoid mesothelioma KG + DL
22 pericardium cancer KG + DL
23 pleural mesothelioma KG + DL
24 well differentiated papillary mesothelioma KG + DL
25 gestational ovarian choriocarcinoma KG + DL
26 childhood malignant neoplasm KG + DL
27 mixed endometrial stromal and smooth muscle tumor KG + DL
28 malignant mesothelioma (disease) KG + DL
29 dermatofibrosarcoma protuberans KG + DL
30 extramammary Paget disease KG + DL
31 heart fibrosarcoma KG + DL
32 fibroblastic neoplasm KG + DL
33 kidney fibrosarcoma KG + DL
34 iminoglycinuria KG + DL
35 conventional fibrosarcoma KG + DL
36 low grade fibromyxoid sarcoma KG + DL
37 hemimegalencephaly KG + DL
38 neoplasm of testis KG + DL
39 epididymal neoplasm KG + DL
40 lipoma of spermatic cord KG + DL
41 epidermal nevus syndrome KG + DL
42 spindle cell liposarcoma KG + DL
43 myxofibrosarcoma KG + DL

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). This report is for research purposes only and does not constitute medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.